Evidence map›Paper›PMID 41458647›Full record

ArticleCureus2025

Symptom Duration as a Predictor of Neurological Recovery After Decompression Surgery for Degenerative Cervical Myelopathy.

Yazan Noufal, Felix Schmitz, Marcus Richter, Philipp Hartung, Philipp Drees, Yama Afghanyar, Martin Naisan

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. One- to two-year outcomes after surgery for cervical myelopathy: a systematic review of symptom duration and baseline severity.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yazan NoufalCenter of Orthopaedics, Spine and Trauma, St. Josefs-Hospital Wiesbaden, Wiesbaden, DEU.
Felix SchmitzCenter of Orthopaedics, Spine and Trauma, St. Josefs-Hospital Wiesbaden, Wiesbaden, DEU.
Marcus RichterCenter of Orthopaedics, Spine and Trauma, St. Josefs-Hospital Wiesbaden, Wiesbaden, DEU.
Philipp HartungCenter of Orthopaedics, Spine and Trauma, St. Josefs-Hospital Wiesbaden, Wiesbaden, DEU.
Philipp DreesDepartment of Orthopaedics and Traumatology, University Medical Center, Johannes Gutenberg University, Mainz, DEU.
Yama AfghanyarDepartment of Orthopaedics and Traumatology, University Medical Center, Johannes Gutenberg University, Mainz, DEU.
Martin NaisanCenter of Orthopaedics, Spine and Trauma, St. Josefs-Hospital Wiesbaden, Wiesbaden, DEU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The impact of symptom duration on postoperative recovery in degenerative cervical myelopathy (DCM) remains controversial. While earlier decompression is often recommended, patient outcomes are likely influenced by a combination of factors. This study aimed to evaluate whether the duration of symptoms significantly affects neurological recovery. Methods We performed a retrospective analysis of 142 consecutive patients (mean age 66.2 years, 63% male) who underwent anterior or posterior cervical decompression. Baseline variables included age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) status, number of stenotic segments, surgical approach, preoperative Japanese Orthopaedic Association (JOA) score, and duration of symptoms. Neurological function was assessed by JOA score preoperatively and at three and 12 months postoperatively. Multivariate linear regression identified independent predictors of continuous JOA change, while multivariate logistic regression assessed factors associated with achieving a clinically meaningful gain (≥1.5 points in JOA score). Results Overall, JOA scores improved by 1.16 ± 2.1 points (8.9%; p < 0.001) at three months and by 1.60 ± 2.2 points (12.2%; p < 0.001) at 12 months. Patients with severe myelopathy (JOA < 12) demonstrated the greatest gains (+1.99 at three months; +4.58 at 12 months; both p < 0.01), whereas those with mild symptoms showed minimal change. In multivariate analysis, a lower baseline JOA score was the sole predictor of greater continuous improvement at three months (p < 0.001) and remained significant at 12 months alongside ASA class (p = 0.017) and BMI (p = 0.027). Symptom duration did not predict the magnitude of continuous change. However, each additional month of preoperative symptoms decreased the odds of achieving a ≥1.5-point gain at three months by 0.7% (p = 0.045). By 12 months, only patient sex (male vs. female; OR: 0.81; p = 0.046) independently predicted clinically meaningful recovery. Conclusion Baseline neurological impairment is the strongest determinant of postoperative improvement in DCM, with systemic health also influencing long-term gains. Although longer symptom duration modestly reduces the likelihood of early clinically meaningful recovery, substantial improvement remains achievable after delay. These findings reinforce the importance of early diagnosis and timely surgical referral.

Indexed as

degenerative cervical myelopathyjoa scoreneurological recoveryprognostic factorssymptom duration

Identifiers

PMID41458647
PMCPMC12740763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.